{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T11:45:08Z","timestamp":1784202308221,"version":"3.55.0"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2015,4,8]],"date-time":"2015-04-08T00:00:00Z","timestamp":1428451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0123582","type":"journal-article","created":{"date-parts":[[2015,4,8]],"date-time":"2015-04-08T18:13:04Z","timestamp":1428516784000},"page":"e0123582","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":115,"title":["A Comparison of Disease Burden in Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis"],"prefix":"10.1371","volume":"10","author":[{"given":"Brigitte","family":"Michelsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragnhild","family":"Fiane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas P.","family":"Diamantopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dag Magnar","family":"Soldal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger Johanne W.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuulikki","family":"Sokka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Kavanaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Haugeberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,4,8]]},"reference":[{"key":"ref1","first-page":"1386","article-title":"Incidence and prevalence of rheumatoid arthritis in the county of Troms, northern Norway","volume":"27","author":"T Riise","year":"2000","journal-title":"J Rheumatol"},{"key":"ref2","first-page":"1918","article-title":"Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway","volume":"32","author":"TM Madland","year":"2005","journal-title":"J Rheumatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/art.21577","article-title":"Incidence and prevalence of ankylosing spondylitis in Northern Norway","volume":"53","author":"G Bakland","year":"2005","journal-title":"Arthritis Rheum"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"DL Scott","year":"2010","journal-title":"Lancet"},{"issue":"Suppl 2","key":"ref5","doi-asserted-by":"crossref","first-page":"ii14","DOI":"10.1136\/ard.2004.032482","article-title":"Psoriatic arthritis: epidemiology, clinical features, course, and outcome","volume":"64","author":"DD Gladman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s40265-014-0191-y","article-title":"Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis","volume":"74","author":"PJ Mease","year":"2014","journal-title":"Drugs"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","article-title":"Ankylosing spondylitis","volume":"369","author":"J Braun","year":"2007","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"M Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","article-title":"The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis","volume":"68","author":"J Sieper","year":"2009","journal-title":"Annals of the Rheumatic Diseases"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3899\/jrheum.120232","article-title":"Pathogenetic overview of psoriatic disease","volume":"89","author":"M Haroon","year":"2012","journal-title":"J Rheumatol Suppl"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.berh.2011.11.006","article-title":"Spondyloarthritides","volume":"25","author":"X Baraliakos","year":"2011","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/annrheumdis-2013-204577","article-title":"Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis","volume":"73","author":"JL Nam","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/annrheumdis-2013-203419","article-title":"Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force","volume":"73","author":"JS Smolen","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/ard.2009.123976","article-title":"Evidence for treating rheumatoid arthritis to target: results of a systematic literature search","volume":"69","author":"M Schoels","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"ref15","first-page":"342","article-title":"Tobacco and other environmental risk factors in rheumatoid arthritis","volume":"8","author":"V Ruiz-Esquide","year":"2012","journal-title":"Reumatol Clin"},{"key":"ref16","first-page":"86","article-title":"Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitis","volume":"33","author":"A Zink","year":"2006","journal-title":"J Rheumatol"},{"issue":"Suppl 1","key":"ref17","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1478-6354-13-S1-S4","article-title":"Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: traditional views, novel insights gained from TNF blockade, and concepts for the future","volume":"13","author":"G Schett","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1477-7525-7-25","article-title":"The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people","volume":"7","author":"F Salaffi","year":"2009","journal-title":"Health Qual Life Outcomes"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3899\/jrheum.090449","article-title":"Identification of cutpoints for acceptable health status and important improvement in patient-reported outcomes, in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis","volume":"37","author":"MK Kvamme","year":"2010","journal-title":"J Rheumatol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"FC Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"W Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/art.1780261107","article-title":"Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire","volume":"26","author":"T Pincus","year":"1983","journal-title":"Arthritis Rheum"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.berh.2007.02.009","article-title":"A proposed continuous quality improvement approach to assessment and management of patients with rheumatoid arthritis without formal joint counts, based on quantitative routine assessment of patient index data (RAPID) scores on a multidimensional health assessment questionnaire (MDHAQ)","volume":"21","author":"T Pincus","year":"2007","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref24","first-page":"2281","article-title":"A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index","volume":"21","author":"A Calin","year":"1994","journal-title":"J Rheumatol"},{"key":"ref25","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"S Garrett","year":"1994","journal-title":"J Rheumatol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"ML Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"R796","DOI":"10.1186\/ar1740","article-title":"Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score","volume":"7","author":"D Aletaha","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/1529-0131(200104)45:2<151::AID-ANR168>3.0.CO;2-T","article-title":"Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis","volume":"45","author":"JA Husted","year":"2001","journal-title":"Arthritis Rheum"},{"key":"ref29","first-page":"1041","article-title":"Comparison of radiological severity in psoriatic arthritis and rheumatoid arthritis","volume":"28","author":"P Rahman","year":"2001","journal-title":"J Rheumatol"},{"key":"ref30","first-page":"668","article-title":"The Swedish early psoriatic arthritis register\u20142-year followup: a comparison with early rheumatoid arthritis","volume":"35","author":"UR Lindqvist","year":"2008","journal-title":"J Rheumatol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/art.10515","article-title":"Preferences for improved health examined in 1,024 patients with rheumatoid arthritis: pain has highest priority","volume":"47","author":"T Heiberg","year":"2002","journal-title":"Arthritis Rheum"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1002\/art.34543","article-title":"Discrepancies between patients and physicians in their perceptions of rheumatoid arthritis disease activity","volume":"64","author":"P Studenic","year":"2012","journal-title":"Arthritis Rheum"},{"key":"ref33","first-page":"2250","article-title":"Incorporating the patient perspective into outcome assessment in rheumatoid arthritis\u2014progress at OMERACT 7","volume":"32","author":"JR Kirwan","year":"2005","journal-title":"J Rheumatol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3899\/jrheum.111393","article-title":"Sex differences in pain scores and localization in inflammatory arthritis: a systematic review and metaanalysis","volume":"39","author":"C Barnabe","year":"2012","journal-title":"J Rheumatol"},{"key":"ref35"},{"key":"ref36","first-page":"S83","article-title":"Challenges comparing functional limitations in rheumatoid arthritis and ankylosing spondylitis","volume":"27","author":"GH Louie","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Gross RL, Schwartzman-Morris JS, Krathen M, Reed G, Chang H, Saunders KC, et al. A comparison of malignancy incidence among psoriatic and rheumatoid arthritis patients in a large US cohort. Arthritis Rheumatol 2014.","DOI":"10.1002\/art.38385"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/annrheumdis-2012-202424","article-title":"Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study","volume":"73","author":"A Ogdie","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/annrheumdis-2011-201194","article-title":"Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review","volume":"72","author":"A Jamnitski","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.22185","article-title":"Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis","volume":"66","author":"M Labitigan","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.3899\/jrheum.100483","article-title":"Comparative analysis of disease activity measures, use of biologic agents, body mass index, radiographic features, and bone density in psoriatic arthritis and rheumatoid arthritis patients followed in a large U.S. disease registry","volume":"37","author":"SM Reddy","year":"2010","journal-title":"J Rheumatol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/rheumatology\/ker349","article-title":"Differences in body mass index among individuals with PsA, psoriasis, RA and the general population","volume":"51","author":"VM Bhole","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/ard.2006.051706","article-title":"Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitors","volume":"65","author":"J Fransen","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1136\/annrheumdis-2012-202035","article-title":"Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the randomised, placebo-controlled GO-REVEAL study","volume":"72","author":"A Kavanaugh","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"ref45","first-page":"S648","article-title":"Routine Assessment Of Patient Index Data 3 Scores Correlate Well With Bath Ankylosing Spondylitis Disease Activity Index In The Assessment Of Disease Activity and Monitoring Progression Of Ankylosing Spondylitis","volume":"65","author":"A Danve","year":"2013","journal-title":"Artritis Rheum"},{"key":"ref46","first-page":"409","article-title":"Similar clinical outcomes in rheumatoid arthritis with more versus less expensive treatment strategies. Observational data from two rheumatology clinics","volume":"31","author":"T Sokka","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"ref47","article-title":"Methotrexate for ankylosing spondylitis","volume":"2","author":"J Chen","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/annrheumdis-2011-200350","article-title":"European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies","volume":"71","author":"L Gossec","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1093\/rheumatology\/kes066","article-title":"First update of the current evidence for the management of ankylosing spondylitis with non-pharmacological treatment and non-biologic drugs: a systematic literature review for the ASAS\/EULAR management recommendations in ankylosing spondylitis","volume":"51","author":"R van den Berg","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm.3260","article-title":"Neurath MF How cytokine networks fuel inflammation: Toward a cytokine-based disease taxonomy","volume":"19","author":"G Schett","year":"2013","journal-title":"Nat Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0123582","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:35:16Z","timestamp":1747874116000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0123582"}},"subtitle":[],"editor":[{"given":"Chi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,4,8]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0123582","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,8]]}}}